Sunedison Inc (NYSE:SUNE)
On Friday, Sunedison Inc (NYSE:SUNE)’s shares inclined 8.48% to $4.93.
EPS ratio was -3.63. The company has 316.72 million shares outstanding while market capitalization of the company was $1.56 billion. Price to book ratio was 1.11. Net profit margin of the company was -62.50% while gross profit margin was 17.60%. Stock volatility for the month was booked as 22.57% while for the week was recorded as 12.08%.
The mean estimate for the short term price target for Sunedison Inc (NYSE:SUNE) stands at $19.53 according to 15 Analysts. The higher price target estimate for the stock has been calculated at $42.00 while the lower price target estimate is at $9.00.
Analysts mean recommendation for the stock is 2.00. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
SunEdison, Inc. (SunEdison) is a developer and seller of photovoltaic energy solutions, an owner and operator of clean power generation assets, and a developer and manufacturer of silicon wafers.
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS)
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS)’s shares dropped -7.98% to $0.0461.
AEZS has the market capitalization of $30.95 billion. The stock has P/B ratio of 0.77 while EPS was $-0.28. Institutional ownership of the company was 21.40% while 632.72 million shares were outstanding. Share of the company moved below its SMA 50 with -34.33%. ROE ratio was -251.50%.
The mean estimate for the short term price target for AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) stands at $0.97 according to 3 Analysts. The higher price target estimate for the stock has been calculated at $1.75 while the lower price target estimate is at $0.15.
Analysts mean recommendation for the stock is 1.70. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Aeterna Zentaris Inc. is a Canada-based specialty biopharmaceutical company engaged in developing treatments in oncology, endocrinology and women’s health.
Costco Wholesale Corporation (NASDAQ:COST)
At the end of Friday’s trade, Costco Wholesale Corporation (NASDAQ:COST)‘s shares dipped -1.49% to $153.67.
COST has market capitalization of $67.22 billion. Its current ratio was 1.00 while its shares were above its 50 days simple moving average with 2.89%. The company offered earning per share of $5.37 while its 437.41 million shares were outstanding. YTD performance of the company was 8.41%. Stock volatility for the week was 1.41% while for the month it was shown at 1.56%.
The mean estimate for the short term price target for Costco Wholesale Corporation (NASDAQ:COST) stands at $162.78 according to 23 Analysts. The higher price target estimate for the stock has been calculated at $185.00 while the lower price target estimate is at $136.00.
Analysts mean recommendation for the stock is 2.10. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Costco Wholesale Corporation (Costco) is engaged in the operation of membership warehouses in the United States (U.S.) and Puerto Rico, Canada, United Kingdom (U.K.), Mexico, Japan, Australia, Spain, and through majority-owned subsidiaries in Taiwan and Korea.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.